We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$905M
AUM Growth
-$6.65M
Cap. Flow
+$9.3M
Cap. Flow %
1.03%
Top 10 Hldgs %
52.46%
Holding
657
New
198
Increased
119
Reduced
86
Closed
223

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$67.4M
2
PFE icon
Pfizer
PFE
+$65.6M
3
APTV icon
Aptiv
APTV
+$29.7M
4
MRNA icon
Moderna
MRNA
+$22.6M
5
CRM icon
Salesforce
CRM
+$19.6M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$85.2M
2
RUN icon
Sunrun
RUN
+$64.1M
3
TPIC
TPI Composites
TPIC
+$31.4M
4
MSFT icon
Microsoft
MSFT
+$30.9M
5
AMZN icon
Amazon
AMZN
+$30.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.6%
2 Healthcare 14.17%
3 Technology 11.37%
4 Financials 4.47%
5 Communication Services 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMKTA icon
151
Ingles Markets
IMKTA
$1.67B
$688K 0.08%
10,412
+550
+6% +$34.9K
PBF icon
152
CALL
PBF Energy
PBF
$7.31B
$687K 0.08%
53,000
-25,000
-32% -$259K
TG icon
153
Tredegar Corp
TG
$310M
$679K 0.08%
55,768
+19,920
+56% +$256K
NLY icon
154
Annaly Capital Management
NLY
$17.4B
$665K 0.07%
19,757
-3,435
-15% -$118K
HTLD icon
155
Heartland Express
HTLD
$956M
$664K 0.07%
41,440
HCKT icon
156
Hackett Group
HCKT
$287M
$661K 0.07%
+33,700
New +$631K
CLAR icon
157
Clarus
CLAR
$143M
$656K 0.07%
25,576
+9,339
+58% +$258K
CRUS icon
158
Cirrus Logic
CRUS
$6.26B
$649K 0.07%
+7,876
New +$655K
ARGX icon
159
argenx
ARGX
$54.1B
$648K 0.07%
2,145
+1,364
+175% +$432K
OGS icon
160
ONE Gas
OGS
$5.04B
$642K 0.07%
10,133
+1,442
+17% +$103K
ES icon
161
Eversource Energy
ES
$27.2B
$641K 0.07%
7,837
-1,226
-14% -$106K
EVTC icon
162
Evertec
EVTC
$1.78B
$636K 0.07%
13,917
+8,900
+177% +$401K
MTD icon
163
Mettler-Toledo International
MTD
$28.6B
$632K 0.07%
+459
New +$691K
ELV icon
164
Elevance Health
ELV
$85.5B
$631K 0.07%
+1,693
New +$643K
PRLB icon
165
Protolabs
PRLB
$2.13B
$627K 0.07%
9,416
+6,632
+238% +$518K
UI icon
166
Ubiquiti
UI
$34.3B
$623K 0.07%
+2,087
New +$645K
MRNA icon
167
PUT
Moderna
MRNA
$23.6B
$616K 0.07%
+1,600
New +$590K
DPZ icon
168
Domino's
DPZ
$11.6B
$614K 0.07%
+1,287
New +$652K
ROK icon
169
Rockwell Automation
ROK
$49B
$609K 0.07%
+2,071
New +$636K
SWKS icon
170
Skyworks Solutions
SWKS
$10.6B
$608K 0.07%
3,692
+2,475
+203% +$453K
CUBE icon
171
CubeSmart
CUBE
$9.41B
$605K 0.07%
+12,494
New +$631K
OLED icon
172
Universal Display
OLED
$4.19B
$602K 0.07%
3,519
+2,008
+133% +$416K
MSGS icon
173
Madison Square Garden
MSGS
$9.39B
$601K 0.07%
3,234
-808
-20% -$138K
LNC icon
174
Lincoln National
LNC
$8.81B
$600K 0.07%
8,730
+1,776
+26% +$116K
EXR icon
175
Extra Space Storage
EXR
$31.6B
$594K 0.07%
+3,533
New +$625K

Similar funds

Caxton Associates (New York)'s Q3 2021 Portfolio in Review

As of Q3 2021, Caxton Associates (New York) held 657 positions worth $905M, down 0.73% from $912M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Caxton Associates (New York)'s Q3 2021 filing shows 198 new, 119 increased, 86 reduced and 223 closed positions. Its largest new stake was Pfizer: 1,480,000 shares worth $63.7M. The largest sale was Baidu, an estimated $85.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • Caxton Associates (New York)'s largest Q3 2021 buy was Pfizer: 1,480,000 shares worth $63.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2021, an estimated $67.4M increase.
  • Caxton Associates (New York)'s biggest Q3 2021 reduction was Sunrun, cutting an estimated $64.1M.
  • Caxton Associates (New York) fully exited Baidu in Q3 2021, selling an estimated $85.2M.
  • Caxton Associates (New York)'s ten largest holdings make up 52% of its $905M portfolio in Q3 2021.
  • Caxton Associates (New York) opened 198 new positions and closed 223 in Q3 2021.
  • Caxton Associates (New York)'s portfolio value fell 0.73% quarter-over-quarter to $905M.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.